Boost Your Focus Fast With the Best Natural Remedies for ADHD
Here's everything you need to know about the foods, nutritional supplements and clever lifestyle tweaks shown to improve focus and increase attention span—while letting all the unique strengths associated with ADHD shine through.
The main signs of ADHD include hyperactivity, impulsivity, lack of executive functioning (managing and finishing tasks), trouble concentrating and emotional dysregulation. A few symptoms, however, may present differently in women, says John J. Ratey, MD, Associate Clinical Professor of Psychiatry at Harvard Medical School, internationally recognized expert in neuropsychiatry and coauthor of Driven to Distraction: Recognizing and Coping with Attention Deficit Disorder and ADHD 2.0.
Anger or aggression is typically more common in boys and men. But in girls and women, that frustration may turn inward, he notes. 'Women may internalize a bit more, meaning instead of yelling at others, they might direct that emotion toward themselves and become depressed.'
There's also a higher prevalence of eating disorders in women with ADHD, adds James Greenblatt, MD, a globally recognized pioneer in functional and integrative psychiatry, developer of the ADHD course Functional Medicine for Mental Health | Mind Refined and author of Finally Focused: The Breakthrough Natural Treatment Plan for ADHD.
Disordered eating, he explains, may be linked to ADHD-induced behaviors like trouble with impulse control and the desire to self-soothe. 'Eating does help the brain concentrate,' notes Dr. Gleenbatt, adding that, like most things in life, it's only when we go overboard that it can become a problem.
Years ago, the ratio of girls to boys who were diagnosed with ADHD was about 1:8; thanks to increasing awareness, today it ranges from 1:2 to 1:4, estimates Dr. Ratey. 'Compared to boys, girls tend to have superior language skills, which can mask other symptoms that might have been identified earlier,' he explains.
Nutrition profoundly affects behavior and brain health, says Dr. Greenblatt. Here he shares the main dos and don'ts of a diet plan designed to manage ADHD symptoms.
'We know that sweetened beverages—everything from Gatorade to sodas—are correlated with ADHD,' Dr. Greenblatt says, explaining that this is in large part because refined sugar depletes B vitamins, which are optimal for brain function.
While there isn't a universal, agreed-upon 'menu' that works for everyone with the condition, research in the journal Pediatrics suggests that a Mediterranean diet may decrease the likelihood of developing ADHD in children and adolescents, confirms Greenblatt. In this case, what's good for the developing brain is just as healthy for the adult brain, so go ahead and fill your plate with veggies, nuts, olive oil and legumes.
Try to make sure you have protein at every meal, since studies suggest it helps steady blood sugar levels. 'While high blood sugar doesn't cause ADHD symptoms, it can make them worse,' Dr. Greenblatt says. Excellent sources of protein include eggs, seafood, lentils and lean meats like poultry.
Drs. Greenblatt and Ratey tick off a few key vitamins and supplements shown to improve focus and overall health, especially for people with ADHD:
Though he acknowledges TikTok may have gotten 'carried away' with extolling the merits of magnesium, Dr. Greenblatt says it's a key supplement that helps reduce ADHD symptoms. 'Close to 100 percent of my patients with ADHD are put on magnesium because it helps with everything from sleep to anxiety to overactivity,' he reveals. He recommends taking 200 to 400 mg of magnesium daily.
Because B vitamins play a key role in energy metabolism, they can help ease hyperactivity and improve focus, notes Dr. Greenblatt. He adds that everyone with ADHD should have their vitamin B levels tested. Talk to your doctor to learn if this supplement is natural ADHD remedy that's right for you, and if so, at what dosage.
Low levels of zinc have long been associated with ADHD. That's likely because the mineral is 'critical to hundreds of enzymes in the body, as well as to neurotransmitter synthesis," Dr. Greenblatt explains. Still, he cautions to avoid taking it over the long-term because too much can lead to a copper deficiency. Dr. Greenblatt suggests aiming for 15 to 30 mg of a zinc supplement daily.
Research shows the fatty acids help 'contain the impulsivity and obsessive-compulsive behaviors sometimes associated with ADHD,' per Dr. Ratey. That's because Omega-3s aid neurotransmitters and are central to brain health. Reap the benefits by taking 250 mg to 500 mg of EPA and DHA daily.
From the simple standing trick that sparks brain activity to the novel way to, well, read a novel, Dr. Ratey shares surprising natural ADHD remedies shown to increase focus.
'The moving brain is the thinking brain,' Dr. Greenblatt declares. 'Regular exercise gives you the same neurotransmitter jolt as the stimulant medications prescribed for ADHD. So, walking or weightlifting a few times a week, for example, will help release dopamine and serotonin—the effects are very similar to Ritalin.'
And if you can take your daily walk with a friend, all the better. Connection and social interaction are key to managing ADHD, he adds. Not only do they bring you joy and purpose, they also light up the brain, as engaging in conversation is a deceptively complex cognitive task.
Tip: Not a fan of walking? Any exercise will do the trick, including a wonderfully nostalgic activity: jumping rope. Dr. Ratey recalls treating a child with ADHD who would have a tantrum every time she sat down to do math homework. 'I told her mom to have her jump rope for five minutes right before sitting down—it helped her focus, and she made it through the work.' Fast forward 30 years and she's more than comfortable with numbers. 'Today, she's a nurse and had to do a lot of math to get where she is,' he shares proudly.
'The attention system in the brain is extremely dependent on the balance system—they're very interactive,' Dr. Ratey says. 'So, when you're at the sink preparing the dishes for the dishwasher, stand on one leg for a few seconds or minutes. Or challenge yourself to put your shorts or pants on standing up without holding on to anything.' The more you practice, the sharper your attention span will become.
Back in the 1980s, when Dr. Ratey was starting his career, one of the treatments for dyslexia was reading while standing up because this simple power pose improves cognition. The same holds true when it comes to natural remedies for ADHD, he explains. 'When you're standing or moving, your brain is already active, spurring greater activity in the attention center.'
For all the ways to corral ADHD, it must be said that it also confers unique strengths. 'People with this condition are often very creative because they see things others don't,' observes Dr. Ratey, who admits to having a large 'swath' of ADHD himself. 'When everyone else is following the leader or the same old doctrinal way of doing things, they make their own path.'
Adds Dr. Greenblatt, 'I don't care whether you use a medicine or a natural approach, ADHD is a neurobiological illness that can be treated. It's not your fault—and it's certainly not a weakness.'
More stories on ADHD:
Do You Struggle With ADHD? Changing Your Diet and Habits in These 5 Ways May Help Ease Symptoms
Empowering Parents of Children with ADHD: Tips and Strategies from the ADHD Thrive Institute
The Unmet Needs of Neurodivergent Children, Lavonne Taylor Appeals for Early Intervention and Support
This content is not a substitute for professional medical advice or diagnosis. Always consult your physician before pursuing any treatment plan.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
34 minutes ago
- CBS News
West Nile Virus confirmed among mosquitoes in Macomb County
West Nile Virus has been confirmed for the first time this summer among mosquitoes in Macomb County, Michigan, local health officials said Thursday. So far, there have been no confirmed human cases of West Nile Virus disease in Michigan. But the Macomb County Health Department said the virus is considered "endemic" in Macomb County in that it is regularly found among local mosquito populations. Because of those circumstances, the health department tests areas during spring and summer where mosquito populations are known to congregate. One of those samplings detected the presence of the virus. "This discovery by our surveillance team is important because it lets us know that this season's mosquitoes are now carrying the virus – which could spread to humans," Andrew Cox, director/health officer of Macomb County Health and Community Services, said in the announcement. Mosquitoes can become infected if they bite a bird that is infected with the virus. If the infected mosquitoes then bite humans, the health department explained, the disease can be transmitted to people. Many of those who are infected will have few to mild symptoms, such as fever or headache. But some people can develop serious complications such as encephalitis, which is inflammation of the brain, or meningitis, which is inflammation of the lining of the brain and spinal cord. People who are at greatest risk of becoming seriously ill include those age 50 and older, those who have received an organ transplant, or those with certain medical conditions such as diabetes or hypertension. Prevention tips To prevent getting West Nile Virus through a mosquito bite, the health department issues the following recommendations: Mosquitoes are most active from dusk to dawn. Those who are outside during that time should wear long pants and long sleeves to protect their skin. Use an insect repellent that contains DEET or picaridin on clothing and exposed skin. The Centers for Disease Control and Prevention suggests the use of oil of lemon eucalyptus should people prefer a more natural repellant. Any buckets, pools or pet dishes that hold standing water should be kept empty or changed frequently to prevent mosquitoes from using that water to lay eggs. Window and door screens should be kept in good repair to prevent mosquitoes from entering inside. The above video first aired Sept. 25, 2024.

Associated Press
38 minutes ago
- Associated Press
Apollo Biowellness, Inc. Re-Files Application with OTCMarkets.com
North Bergen, New Jersey--(Newsfile Corp. - July 3, 2025) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the 'Company') announces that it submitted to an application to be able to file disclosure reports on OTCIQ. The application process includes a review by and is pending approval by [ This image cannot be displayed. Please visit the source: ] Evolutionary Biologics Ad Campaign To view an enhanced version of this graphic, please visit: James W. Zimbler, President, stated, 'Our application to resume submitting disclosure statements and financial information has been submitted and we are awaiting final approval. As soon as final approval is granted, we will be filing the necessary statements.' You can follow and contact the Company on X at @ApolloBioKOAN. About Apollo Biowellness, Inc. Apollo Biowellness, Inc., and its subsidiary, Evolutionary Biologics, Inc., is engaged in the discovery, development and marketing of products designed to better mankind. We believe we are positioning our company as a leader in the field of Regenerative Medicine as defined by the National Institute of Health using biologic based products. Intended products are to be marketed under third-party label exemptions. We are focusing our current efforts on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. Also, we are licensed under a patent-pending application to market a dual acting all-natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Products are being developed for consumer and professional markets. Before using any of our products, you should always consult with your veterinarian and/or family doctor. Forward-Looking StatementsCorporate Contact James W. Zimbler President/CEO/Director [email protected] 631-806-1420 To view the source version of this press release, please visit


Associated Press
38 minutes ago
- Associated Press
GeoVax Highlights Critical Role of Multi-Antigen COVID-19 Vaccines as Nimbus Variant Underscores Persistent and Evolving Public Health Threat
With COVID-19 continuing to mutate and over 40 million immunocompromised Americans still at risk, GeoVax's GEO-CM04S1 vaccine offers potential broader, more durable protection through a unique multi-antigen approach ATLANTA, GA - July 3, 2025 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today emphasized the urgent need for innovation in COVID-19 vaccination as the NB.1.8.1 variant - commonly known as 'Nimbus' - spreads rapidly across the globe. Nimbus, a highly transmissible Omicron subvariant classified by the World Health Organization as a 'Variant Under Monitoring,' is now dominant in multiple U.S. states and surging across Europe and Asia. Though not more severe, its rapid spread and potential for immune escape reflect an increasingly clear reality: COVID-19 is not going away, and it will continue to evolve. 'The emergence of the Nimbus variant is a stark reminder that we need 'smarter' vaccines, not just newer ones,' said David Dodd, Chairman and CEO of GeoVax. 'Our GEO-CM04S1 vaccine was designed for this purpose and is built to potentially provide broader and longer-lasting protection, especially for the immunocompromised patients most at risk.' GEO-CM04S1: Multi-Antigen Protection for the Immunocompromised Unlike mRNA vaccines that rely solely on the Spike protein, GEO-CM04S1 delivers both Spike (S) and Nucleocapsid (N) antigens, stimulating an immune response that includes not only an antibody response, but also robust T-cell activity. This is believed to be critical for cross-variant protection and extended durability, particularly in individuals with weakened immune systems. GEO-CM04S1 is currently being evaluated in two Phase 2 clinical trials, focused on populations at greatest risk from COVID-19 complications, including blood cancer patients scheduled to receive stem cell transplant therapy. In one of the ongoing Phase 2 trials, the mRNA control arm was discontinued due to poor immunogenicity with the remainder of the trial only including GEO-CM04S1 which surpassed the immunogenicity target, reinforcing the limitations of monovalent vaccines and the important value of a multi-antigen vaccine approach in such high-risk patient populations. 'There are more than 40 million immunocompromised individuals in the U.S. alone,' said Dodd. 'They are underserved by the current, FDA-approved vaccine options that deliver only an antibody response and require a better solution with both breadth and longevity of protection.' Public Vaccine Policy and Regulatory Changes Support Platform Diversification Recent guidance from the U.S. Food and Drug Administration (FDA) calls for diversified vaccine platforms and risk-based regulatory pathways. Additionally, the CDC's narrowed 2025–2026 booster recommendations - now focused on adults 65+ and immunocompromised individuals - closely mirror GeoVax's clinical strategy and target population. GEO-CM04S1 has been proposed under BARDA's Rapid Response Partnership Vehicle (RRPV) for surge manufacturing support and integration into long-term public health preparedness efforts. The proposal, 'Innovation in Clinical Manufacturing of MVA-Vectored COVID-19 Vaccines', was selected by the RRPV, pending funding availability. 'As public health moves toward more targeted, durable, and inclusive vaccination strategies, GEO-CM04S1 is positioned to deliver where first generation COVID-19 vaccines fall short,' Dodd added. In addition to targeting today's variants, GEO-CM04S1 is structurally designed to adapt to future mutations and serve as a platform for multi-pathogen preparedness. As part of GeoVax's broader MVA-based portfolio, the platform underpins vaccine candidates for Mpox, smallpox, and hemorrhagic fever viruses, offering scale and flexibility across infectious disease threats. About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines against infectious diseases and therapies for solid tumor cancers. The Company's lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin(R), having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax is also developing a vaccine targeting Mpox and smallpox and, based on recent regulatory guidance, anticipates progressing directly to a Phase 3 clinical evaluation, omitting Phase 1 and Phase 2 trials. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. For more information about the current status of our clinical trials and other updates, visit our website: Forward-Looking Statements This release contains forward-looking statements regarding GeoVax's business plans. The words 'believe,' 'look forward to,' 'may,' 'estimate,' 'continue,' 'anticipate,' 'intend,' 'should,' 'plan,' 'could,' 'target,' 'potential,' 'is likely,' 'will,' 'expect' and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax's immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax's viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax's immuno-oncology products and preventative vaccines will be safe for human use, GeoVax's vaccines will effectively prevent targeted infections in humans, GeoVax's immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Company Contact: [email protected] 678-384-7220 Investor Relations Contact: [email protected] 212-698-8696 Media Contact: Jessica Starman [email protected]